Webinars

Nourishing Recovery: Managing Malnutrition and Muscle Loss in Cancer Care

What can healthcare professionals do to address malnutrition and muscle loss in cancer care?

Presenter(s): Jillian Hyttenhove, MA, RD, CSOWM, LD, CHES

Carley Rusch, PhD, RDN, LDN

Amy Sharn, MS, RDN, LD

Date: 26 August 2026

Time: Noon-1 PM ET

Location: Live webinar

Continuing Education Credits: Nurse Contact 1.0 CE; Dietitian 1.0 CPEU

Summary

This program highlights the significant impact of malnutrition and muscle loss on cancer treatment outcomes, recovery, and quality of life. This program reviews the prevalence of malnutrition and its association with poorer clinical outcomes and the role of early nutrition intervention. Participants will gain practical, evidence-based strategies to support nutrition and muscle throughout and beyond cancer treatment, improving overall patient care.

Webinar Flyer

Nourishing Recovery: Managing Malnutrition and Muscle Loss in Cancer Care

Learning Objectives:

  • Review the prevalence of malnutrition and the association between malnutrition and cancer outcomes
  • Discuss health economics and outcomes research supporting nutrition interventions
  • Examine the consequences of low muscle mass on cancer outcomes and discuss intervention strategies to support muscle during and after cancer treatment

Key Takeaways:

  • Malnutrition is common in patients with cancer and associated with poor outcomes, readmissions, longer LOS and higher cost of care 
  • Interventions that seek to improve nutrition are associated with:
    • Reduction in length of stay and readmission rates
    • Cost savings
    • Improved quality of life for patients with cancer

Related Questions:

  • How does early nutrition assessment and intervention affect outcomes in patients with cancer?
    Early and proactive nutrition assessment is associated with significantly better outcomes, including losing less weight, better treatment completion rates, lower unplanned hospital admissions, and decreased hospital length of stay.
  • What are the benefits of oral nutrition supplements (ONS) in patients with cancer?
    ONS have been associated with several positive outcomes including reduction in readmissions and length of stay. When combined with dietary counseling, ONS use is associated with improved quality of life, reduced weight loss, and lower likelihood of treatment dose reductions or treatment interruptions.
  • Why is monitoring body weight alone insufficient for assessing nutritional status in patients with cancer?
    Patients may lose muscle despite their weight remaining stable or they may develop sarcopenia. Low muscle mass is associated with poorer survival, increased complications, and lower quality of life, making assessment of muscle an important component of cancer care.

Presenter Bio(s):

Jillian Hyttenhove, MA, RD, CSOWM, LD, CHES

Medical Science Liaison
Medical Affairs & Research
Abbott Nutrition
Columbus, OH, USA

Jillian Hyttenhove is a Medical Science Liaison at Abbott Nutrition. Prior to joining Abbott, she worked in corporate wellness for several large national and global companies.

Jillian completed her bachelor’s degree in Dietetics at Bowling Green State University and her dietetic internship at East Carolina University. She went on to complete her Master of Arts in Health Education at East Carolina University as well. Following the completion of her dietetic internship, she served as the lead outpatient dietitian for all outpatient services at a community hospital in North Carolina. She then collaborated with a lead obesity specialist to create a comprehensive weight management program at the University of North Carolina, where she also served as a research dietitian on clinical trials.

Jillian is a Registered Dietitian, a Board-Certified Specialist in Obesity and Weight Management, and a Board-Certified Specialist in Health Education.

Carley Rusch, PhD, RDN, LDN

Medical Science Liaison
Abbott Nutrition 
Columbus, OH, USA

Carley Rusch serves as a Medical Science Liaison in Medical Affairs & Research at Abbott, specializing in Adult Therapeutic Nutrition. Prior to joining Abbott, Dr Rusch completed her bachelor’s degree in Food Science and Human Nutrition at the University of Florida (UF), specializing in Dietetics. She earned her master’s degree and completed her dietetic internship through the MS-DI program at UF. During her dietetic training, she also served as a research coordinator on a variety of study protocols, including topics on gastrointestinal dysfunction, inflammation, pre- and probiotics, and the gut microbiome. She then worked as an inpatient dietitian at AdventHealth Orlando and served as a preceptor for its dietetic internship program. Her clinical experience spans a variety of disease states, such as cancer, gastrointestinal and neurological disorders, malnutrition, and critical care. 

Following her time working in clinical practice, Dr Rusch completed her PhD in Nutritional Sciences at UF. Her doctoral research investigated the effect of the Mediterranean diet on improving constipation and intestinal inflammation in Parkinson’s disease. During her graduate programs, she has taught multiple undergraduate and graduate courses on nutrition, metabolism, and research methods. In 2020, she was awarded the Recognized Young Dietitian of the Year by the Florida Academy of Nutrition and Dietetics. Dr Rusch has several publications in peer-reviewed journals and has been invited to present at national and international conferences.

Amy R Sharn, MS, RDN, LD

Senior Scientist, Real-World Evidence
Medical Affairs & Research
Abbott Nutrition
Columbus, OH, USA

Amy Sharn, MS, RDN, LD is a Senior Scientist and Registered Dietitian Nutritionist with Abbott’s Global Health Economics, Outcomes Research, Real-World Evidence, and Implementation Science team. As part of the larger Global Medical Affairs and Research team, she supports the global nutrition business with design and dissemination of real-world evidence and quality improvement projects for nutrition products, which measure the impact of nutrition interventions on process and patient outcomes in addition to healthcare costs.

Category

References: 

  • Trujillo EB, et al. J Oncol. 2019;2019:7462940.
  • Kadakia KC, et al. Support Care Cancer. 2022;30(3):2237-2244.
  • Kiss N, et al. JPEN J Parenter Enteral Nutr. 2026;50(3):274-338.
  • Cornejo-Pareja I, et al. Nutrients. 2025;17(17):2854.
  • Orsso CE, et al. Am J Clin Nutr. 2024;120(6):1311-1324.